Consumables Segment to Dominate Europe Long Read Sequencing Market during 2021–2028

  According to a new market research study on “Europe Long Read Sequencing Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Technology, Product, Application, Workflow and End User” is expected to reach US$ 1,617.47 million by 2028 from US$ 384.94 million in 2021. The market is estimated to grow at a CAGR of 22.8% from 2021 to 2028. The report provides trends prevailing in the Europe long read sequencing market along with the drivers and restraints pertaining to the market growth. Surge in prevalence of chronic diseases is the major factor driving the growth of the Europe long read sequencing market. However, issues associated with the dearth of skilled professionals hinder the growth of Europe long read sequencing market.

The Europe long read sequencing market is segmented based on technology, product, application, workflow and end user, and country. Based on technology, the long read sequencing market is sub-segmented into single-molecule real-time sequencing (SMRT), nanopore sequencing, and loop genomics long-read sequencing. The single-molecule real-time sequencing (SMRT) segment dominated the market in 2020 and loop genomics long-read sequencing segment is expected to be the fastest growing during the forecast period. Based on product, the long read sequencing market is categorized into instruments, consumables, and services. The consumables segment dominated the market in 2020 and services segment is expected to be the fastest growing during the forecast period. Based on application, the market is segmented into identification and fine mapping of structural variation, tandem repeat sequencing, pseudogene discrimination, resolving allele phasing, reproductive genomics, cancer, viral and microbial sequencing. The identification and fine mapping of structural variation segment dominated the market in 2020 and cancer segment is expected to be the fastest growing during the forecast period. Based on workflow, the market is segmented pre-sequencing, sequencing, and data analysis. The sequencing segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on end user, the long read sequencing market is sub-segmented into academic research institutes, hospitals and clinics, and pharma and biotechnology companies. The academic research institutes, hospitals and clinics segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on country, the market is segmented into UK, Germany, France, Italy, and Spain.

Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. European countries are observing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Many countries are declaring more cases each day now than during the first wave earlier this year. Lockdowns are being reintroduced in the UK, Spain, Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Due to the second wave of COVID-19 cases, many countries' government is working towards boosting up their genomic sequencing to know the virus and build treatment against it. Unfortunately, the UK Government's tiered plan to easing a month-long lockdown in early December failed to curb the spread of the viral pandemic – especially in London, the East, and the South East of England. Whole viral genome sequencing also allows for a better understanding of the transmission of the virus, including whether it is mutating and becoming a threat to people. In addition, genomics can assist in explaining why people respond to Covid-19 in different ways, therefore aiding to identify and better protect those at greater risk of severe disease. The demand for the genomic increased drastically owing to supportive government initiatives. For instance, the efforts of UK public health agencies and with the support of the Covid-19 Genomics Consortium UK (COG-UK) created in late March 2020 with £20m funding from UK Research and Innovation, COG-UK is bringing together researchers from 16 sites across the UK, including the Wellcome Sanger Institute, to sequence positive samples of SARS-CoV-2 to track the development of mutations and how they are spreading. Moreover, COG-UK and the Sanger Institute have raised £12.2m in funding from the Department of Health and Social Care's Testing Innovation Fund to create a real-time surveillance system of emerging outbreaks. This system will be supported by new software being developed by the Sanger Institute and involves researchers from across the consortium's network. In addition, deCODE genetics is also conducting demonic analysis of COVID-19 virus, partnering with the government of Iceland to sequence the genomes of the samples isolated from COVID-19 patients. Hence, the European genomic market is likely to show significant growth prospects during this pandemic and forecasted year.

BaseClear B.V.; Bionano Genomics; F. HOFFMANN-LA ROCHE LTD.; Illumina, Inc.; Oxford Nanopore Technologies; PerkinElmer, Inc.; and TATAA Biocenter among the leading companies in the Europe long read sequencing market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, The Oxford Nanopore Ultra-Long DNA Sequencing Kit, when used in conjunction with Circulomics Nanobind Kits, is designed to maximise the number of ultra-long reads and has allowed the continuous sequencing of single DNA fragments of up to 3+ Mb externally and 4+ Mb internally. Using this method, users can achieve more than 100 reads over 1 Mb per PromethION flow cell run.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com